{{Rsnum
|rsid=952621
|Gene=LARS2
|Chromosome=3
|position=45435202
|Orientation=minus
|GMAF=0.1809
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=LARS2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 69.0 | 29.2 | 1.8
| HCB | 70.1 | 27.7 | 2.2
| JPT | 56.6 | 37.2 | 6.2
| YRI | 73.5 | 25.9 | 0.7
| ASW | 80.7 | 14.0 | 5.3
| CHB | 70.1 | 27.7 | 2.2
| CHD | 68.8 | 29.4 | 1.8
| GIH | 77.2 | 21.8 | 1.0
| LWK | 79.1 | 20.0 | 0.9
| MEX | 82.8 | 15.5 | 1.7
| MKK | 83.2 | 16.8 | 0.0
| TSI | 47.1 | 48.0 | 4.9
| HapMapRevision=28
}}

A 2009 study of 11,163 Dutch participants found no evidence to support previous data indicating a role for SNPs in this gene ([[LARS2]]) in type 2 diabetes susceptibility.{{PMID|19847392|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}